Medindia LOGIN REGISTER
Medindia
Advertisement

Webcast Alert: Derma Sciences, Inc. Announces the LHA Life Sciences & Med Tech Day 2010 Presentation

Thursday, July 15, 2010 Corporate News
Advertisement


NEW YORK, July 14 Derma Sciences, Inc. (Nasdaq: DSCI) announces the following Webcast:

If you are unable to participate during the live webcast, the call will be available for replay at http://www.investorcalendar.com/ClientPage.asp?ID=160488 or http://www.investorcalendar.com/
Advertisement

Derma Sciences is a global medical device and pharmaceutical company focused on wound care. Its MEDIHONEY® product is the leading brand of honey-based dressings for the management of wounds and burns. The product has been shown to be effective in a variety of indications, and was the focus of a positive large-scale, randomized controlled trial involving 108 leg ulcer patients. Other novel products introduced into the $14 billion global wound care market include XTRASORB® for better management of wound exudates, and BIOGUARD(TM) for infection prevention. Derma Sciences also expects to complete preclinical studies with DSC127, a novel pharmaceutical for accelerated wound healing and scar reduction, by the end of 2010. For more information please visit www.dermasciences.com.
Advertisement

What: LHA Life Sciences & Med Tech Day 2010 Presentation When: July 20, 2010 @ 11:30 AM Eastern Where: http://www.investorcalendar.com/ClientPage.asp?ID=160488 Live over the Internet --Simply log on to the web at How: the address above. Contact: Cheryl Palazzo, 212-838-3777, [email protected]

SOURCE Derma Sciences, Inc.
Sponsored Post and Backlink Submission


Latest Press Release on Corporate News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close